Vol 48 No 12
Advertisement
Advertisement
Trending on Urology Times
1
Experts urge FDA to revisit labeling for testosterone replacement therapy in men
2
FDA approves flibanserin for hypoactive sexual desire disorder in postmenopausal women
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
5
